Boothbay Fund Management’s Pfizer PFE Stock Holding History

Boothbay Fund Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,800	Closed	-$1.04M	–	2376
2025 Q4	$1.04M	Buy	+41,800	New	+$1.05M	0.02%	783
2024 Q3	–	Sell	-62,800	Closed	-$1.76M	–	1847
2024 Q2	$1.76M	Buy	+62,800	New	+$1.73M	0.04%	547
2023 Q4	–	Sell	-40,000	Closed	-$1.33M	–	1894
2023 Q3	$1.33M	Buy	+40,000	New	+$1.41M	0.03%	643
2023 Q1	–	Sell	-250,700	Closed	-$12.8M	–	2422
2022 Q4	$12.8M	Buy	250,700 +239,000	+2,043%	+$11.5M	0.3%	38
2022 Q3	$512K	Buy	11,700 +6,000	+105%	+$292K	0.01%	1217
2022 Q2	$299K	Sell	5,700 -13,900	-71%	-$708K	0.01%	1467
2022 Q1	$1.01M	Sell	19,600 -14,000	-42%	-$726K	0.02%	891
2021 Q4	$1.98M	Buy	+33,600	New	+$1.66M	0.05%	490
2021 Q1	–	Sell	-324	Closed	-$1.19M	–	1729
2020 Q4	$1.19M	Buy	324 +199	+159%	+$7.3K	0.04%	439
2020 Q3	$437K	Buy	+125	New	+$4.38K	0.03%	690
2018 Q2	–	Sell	-165	Closed	-$557K	–	861
2018 Q1	$557K	Buy	+165	New	+$5.67K	0.07%	298

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boothbay Fund Management's PFE Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Pfizer (PFE) in Q2 2026: 194,734 shares worth $4.69M. The stake represents 0.06% of the portfolio and ranks #376 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in PFE as recently as Q4 2025.

Boothbay Fund Management first reported a position in PFE in Q4 2014 and has held it in 19 quarters since. The position peaked at $72.4M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Boothbay Fund Management held 194,734 shares of Pfizer worth $4.69M as of Q2 2026.
Pfizer was a new Boothbay Fund Management position in Q2 2026.
Pfizer made up 0.06% of Boothbay Fund Management's portfolio in Q2 2026, its #376 holding.
Boothbay Fund Management first reported a position in Pfizer in Q4 2014 and has held it in 19 quarters since.
Boothbay Fund Management's Pfizer position peaked at $72.4M in Q4 2021.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.